Scientific Advisory Board
STEVEN GOLDSTEIN, PH.D.
Dr. Goldstein is the Henry Ruppenthal Family professor of Orthopaedic Surgery and Bioengineering, professor in the Departments of Mechanical Engineering and Biomedical Engineering and associate chair for research in the Department of Orthopaedic Surgery at the University of Michigan. He has spent more than 25 years studying the mechanical and biologic influences on bone adaptation, formation and repair, and has developed a variety of orthopaedic implants and tissue engineering strategies for bone and wound repair.
ALBERTO HAYEK, M.D.
Dr. Hayek is a research professor of Pediatrics at University of California, San Diego (UCSD) and scientific director of the Whittier Institute for Diabetes. He has more than 20 years experience in diabetes research and was first to demonstrate that human islets replicate in vitro. Dr. Hayek also identified endocrine cell progenitors in the human fetal pancreas by developing protocols for fetal cell transplantation widely used today in research. For the last five years, he has studied the differentiation of both embryonic and iPSCs into insulin-producing cells.
SUI HUANG, M.D., PH.D.
Dr. Huang is an associate professor in the Institute of Biocomplexity and Informatics at the University of Calgary. He distills high-density data generated by quantitative biology to answer the questions of what is the essence of “stemness” and how cells make decisions to become specific cell types.
MARK KRASNOW, M.D., PH.D.
Dr. Krasnow is professor and chair of the Department of Biochemistry at Stanford University School of Medicine and investigator of the Howard Hughes Medical Institute. He researches the genetic, cellular, and molecular mechanisms of lung formation for better understanding of and treatments for lung diseases.
ROBERT S. LANGER, JR., SC.D.
Dr. Langer is the Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering, Massachusetts Institute of Technology. He is the former Chairman of the FDA Science Board, the FDA's highest advisory board, and has written 780 articles and 450 abstracts, and has nearly 500 issued or pending patents. Dr. Langer has received over 100 major awards, including the 2002 Charles Stark Draper Prize, considered the world's most prestigious engineering prize.
LYNN MEGENEY, PH.D.
Dr. Megeney is the Mach Gaensslen chair in cardiac research, professor in the departments of medicine and cellular and molecular biology at the University of Ottawa and a senior scientist in the regenerative medicine program at OHRI. He has made breakthrough discoveries relating to cardiac muscle and pancreatic regeneration.
SEAN MORRISON, PH.D.
Dr. Morrison is the director of the University of Michigan Center for Stem Cell Biology, professor in the Department of Internal Medicine, research professor in the Life Sciences Institute, and investigator of the Howard Hughes Medical Institute. He investigates the mechanisms that regulate stem cell function in the hematopoietic and nervous systems.
STUART ORKIN, M.D.
Dr. Orkin is the chair of the Department of Pediatric Oncology at Dana-Farber Cancer Institute, David G. Nathan professor of pediatrics at Harvard Medical School, member of the Harvard Stem Cell Institute and investigator of the Howard Hughes Medical Institute at Children’s Hospital Boston. He researches the development and function of the blood system, the relationship between cancer and stem cells and the mechanisms responsible for self-renewal of stem cells.
BENNETT M. SHAPIRO, M.D.
Dr. Shapiro served as an Executive Vice President at Merck & Co. from 1990 to 2003. Dr. Shapiro is the former head of Worldwide Licensing and External Research at Merck. Prior to that, he served as the head of basic and preclinical research at Merck & Co. and as Chairman of the Biochemistry Department at University of Washington.